-
Cost-Effectiveness Analysis of Ga-PSMA-11 PET/CT Imaging Followed by Lu-PSMA-617 vs. Standard of Care in Metastatic Castrate-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
Gender Differences in the Economic Burden of Alcohol Use in Belgium
Sep 9, 2025, 16:22 PM -
Enterocutaneous Fistula (ECF) and Economic Burden Preliminary Data From a HEOR Model of a Laboratory (LAB) Experiment Plus Potential Cost Avoidance
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
The Role of Qualitative Research in Randomized Controlled Trials Involving Drugs and Medical Devices: A Systematic Mapping Review
Sep 9, 2025, 16:22 PM -
Disability Resource Utilization and Caregiver Support Among a Real-World Sample of Patients With Transthyretin Amyloidosis With Polyneuropathy
Sep 9, 2025, 16:22 PM -
Comparative Epidemiological Burden of Osteoarthritis in Eastern Central and Western Europe Based on the Global Burden of Disease Study 2021
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Medical Interventions for Adult People Living With Obesity: Protocol for a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Evolution of Manufacturer-Set List Prices and GKV Rebates for Orphan Drugs (OD) in Germany 2013-2024: How Much US WAC Is in German OD-Prices
Sep 9, 2025, 16:22 PM -
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Using Site-Specific Wastewater-Based Surveillance to Monitor COVID-19 in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
NICE Has Embraced Single-Arm Trials in Technology Appraisals but Where Is the Guidance?
Sep 9, 2025, 16:22 PM -
Characteristics of DNAR Orders Among Non-Critically Ill Extremely Elderly Patients Admitted to a University Hospital in Japan
Sep 9, 2025, 16:22 PM -
Estimating the Cost-Effectiveness of Tumor-Treating Fields With Gemcitabine and Nabpaclitaxel for Frontline Treatment of Locally Advanced Pancreatic Adenocarcinoma
Sep 9, 2025, 16:22 PM -
Evaluating the Efficacy of Artificial Intelligence Models as Suitable Screening Tools in Systematic Reviews: The Example of Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure Treatment
Sep 9, 2025, 16:22 PM -
Analytical Modeling in Economic Evaluations of Obesity Interventions to Inform Health Policy: A Narrative Review
Sep 9, 2025, 16:22 PM -
Impact of Higher-Valent Pediatric Pneumococcal Vaccines on Hospitalization Burden in Norway
Sep 9, 2025, 16:22 PM -
Consideration of Off-Label Therapies as Appropriate Comparator Therapy in Early Benefit Assessments in Germany Under the ALBVVG Legislation
Sep 9, 2025, 16:22 PM -
Standardizing Point-of-Care mRNA-Based Gene Therapy Production in Europe: A Cost and Capacity Analysis of the Nanospresso Platform
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Coblation Intracapsular Tonsillectomy in the Management of Sleep-Disordered Breathing and Recurrent Tonsillitis: A Brazilian Perspective
Sep 9, 2025, 16:22 PM
